Definitive Healthcare Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2026 Annual Meeting of Stockholders held on June 4, 2026. The filing covers corporate governance matters, including director elections, auditor ratification, equity plan amendments, and executive compensation votes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the outcomes of stockholder votes.
Material Changes and Voting Results
Stockholders approved all four proposals presented at the Annual Meeting. Key outcomes include:
- Director Elections: All three Class II nominees (Chris Egan, Sastry Chilukuri, Samuel A. Hamood) were elected to serve until the 2029 annual meeting.
- Auditor Ratification: Deloitte & Touche LLP was ratified as the independent auditor for fiscal year 2026.
- Equity Plan Amendment: Stockholders approved an increase of 15,000,000 shares in the 2021 Equity Incentive Plan, raising the total authorized shares from 30,972,789 to 45,972,789.
- Executive Compensation: The advisory vote on named executive officer compensation was approved.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves as a record of the completed voting process.
Investor Verification Checklist
- Verify the final share count for the 2021 Equity Incentive Plan (45,972,789 shares) in subsequent filings.
- Review the definitive proxy statement filed on April 23, 2026, for detailed biographies of the newly elected directors.
- Confirm the specific terms of the executive compensation package approved in the advisory vote.
- Monitor future filings for the impact of the increased equity pool on potential dilution.